Dihydroartemisinin is a Hypoxia-Active Anti-Cancer Drug in Colorectal Carcinoma Cells
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dihydroartemisinin is a Hypoxia-Active Anti-Cancer Drug in Colorectal Carcinoma Cells
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 4, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2014-05-19
DOI
10.3389/fonc.2014.00116
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antiapoptotic potency of Bcl-2 proteins primarily relies on their stability, not binding selectivity
- (2014) R. W. Rooswinkel et al. BLOOD
- DHA regulates angiogenesis and improves the efficiency of CDDP for the treatment of lung carcinoma
- (2013) Jia-Li Zhang et al. MICROVASCULAR RESEARCH
- Ionizing Radiation Potentiates Dihydroartemisinin-Induced Apoptosis of A549 Cells via a Caspase-8-Dependent Pathway
- (2013) Tongsheng Chen et al. PLoS One
- BCL2L11/BIM
- (2012) Shouqing Luo et al. Autophagy
- Host Immune Defense Peptide LL-37 Activates Caspase-Independent Apoptosis and Suppresses Colon Cancer
- (2012) S. X. Ren et al. CANCER RESEARCH
- The Intrinsic Apoptosis Pathways as a Target in Anticancer Therapy
- (2012) Verena Jendrossek CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Dihydroartemisinin/Piperaquine
- (2012) Gillian M. Keating DRUGS
- DNase activation by hypoxia–acidosis parallels but is independent of programmed cell death
- (2012) John W. Thompson et al. LIFE SCIENCES
- Pharmacokinetic profiles of artesunate following multiple intravenous doses of 2, 4, and 8 mg/kg in healthy volunteers: Phase 1b study
- (2012) Robert Miller et al. MALARIA JOURNAL
- Hypoxia modulates the effect of dihydroartemisinin on endothelial cells
- (2011) S. D’Alessandro et al. BIOCHEMICAL PHARMACOLOGY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012
- (2011) L Galluzzi et al. CELL DEATH AND DIFFERENTIATION
- Hypoxia-mediated drug resistance: Novel insights on the functional interaction of HIFs and cell death pathways
- (2011) Nadine Rohwer et al. DRUG RESISTANCE UPDATES
- Anti-tumor effects of dihydroartemisinin on human osteosarcoma
- (2011) Ye Ji et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Artesunate Induces Oxidative DNA Damage, Sustained DNA Double-Strand Breaks, and the ATM/ATR Damage Response in Cancer Cells
- (2011) N. Berdelle et al. MOLECULAR CANCER THERAPEUTICS
- Dihydroartemisinin Induces Apoptosis by a Bak-Dependent Intrinsic Pathway
- (2010) R. Handrick et al. MOLECULAR CANCER THERAPEUTICS
- Mitochondrial Regulation of Cell Survival and Death During Low-Oxygen Conditions
- (2009) Colleen M. Snyder et al. ANTIOXIDANTS & REDOX SIGNALING
- The additional loss of Bak and not the lack of the protein tyrosine kinase p56/Lck in one JCaM1.6 subclone caused pronounced apoptosis resistance in response to stimuli of the intrinsic pathway
- (2009) J. Rudner et al. APOPTOSIS
- Anti-cancer effects of artesunate in a panel of chemoresistant neuroblastoma cell lines
- (2009) Martin Michaelis et al. BIOCHEMICAL PHARMACOLOGY
- BCL-xL Is a Target Gene Regulated by Hypoxia-inducible Factor-1α
- (2009) Ni Chen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The BCL-2 protein family: opposing activities that mediate cell death
- (2007) Richard J. Youle et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started